Aldosterone potentiates 1,25-dihydroxyvitamin D3 action in renal thick ascending limb via a nongenomic, ERK-dependent pathway

David Good, Thampi George, Bruns Watts

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Recently, we demonstrated that aldosterone inhibits HCO3 - absorption in the rat medullary thick ascending limb (MTAL) via a nongenomic pathway blocked by inhibitors of extracellular signal-regulated kinase (ERK) activation. Here we examined the effects on the MTAL of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], which regulates cell functions through nongenomic mechanisms in nonrenal systems. Addition of 1 nM 1,25(OH)2D3 to the bath decreased HCO3 - absorption by 24%, from 15.0 ± 0.3 to 11.4 ± 0.5 pmol·min-1·mm-1 (P < 0.001). This inhibition was maximal within 60 min and was eliminated by pretreatment with actinomycin D, cycloheximide, or inhibitors of protein kinase C. In MTAL bathed with 1 nM aldosterone [added 15-20 min before 1,25(OH)2D 3], the absolute (5.6 ± 0.3 vs. 3.6 ± 0.3 pmol·min-1·mm-1) and fractional (49 ± 2 vs. 24 ± 2%) decreases in HCO3 - absorption induced by 1,25(OH)2D3 were significantly greater than those in the absence of aldosterone (P < 0.05). The effect of aldosterone to potentiate inhibition by 1,25(OH)2D3 was not affected by spironolactone but was eliminated by the MAPK kinase/ERK inhibitor U-0126. U-0126 did not affect inhibition of HCO3 - absorption by 1,25(OH)2D3 alone. Aldosterone induced rapid activation of ERK via a transcription-independent pathway. We conclude that 1) 1,25(OH)2D3 inhibits HCO3 - absorption in the MTAL via a genomic pathway involving protein kinase C, which may contribute to 1,25(OH)2D3-induced regulation of urinary net acid and/or Ca2+ excretion and 2) aldosterone potentiates inhibition by 1,25(OH)2D3 through an ERK-dependent, nongenomic pathway. These results identify a novel regulatory interaction whereby aldosterone acts via nongenomic mechanisms to enhance the genomic response to 1,25(OH)2D3. Aldosterone may influence a broad range of biological processes, including epithelial transport, by modifying the response of target tissues to 1,25(OH)2D 3 stimulation.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Cell Physiology
Volume285
Issue number5 54-5
StatePublished - Nov 2003

Fingerprint

Calcitriol
Extracellular Signal-Regulated MAP Kinases
Aldosterone
Extremities
Kidney
Protein Kinase C
Chemical activation
Biological Phenomena
Spironolactone
Mitogen-Activated Protein Kinase Kinases
Dactinomycin
Transcription
Cycloheximide
Baths
Rats
Tissue
Acids

Keywords

  • 1,25-dihydroxycholecalciferol
  • Acid-base transport
  • Bicarbonate absorption
  • Calcium homeostasis
  • Kidney

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

@article{833fde09166c44db9d9c5e0d26ea2901,
title = "Aldosterone potentiates 1,25-dihydroxyvitamin D3 action in renal thick ascending limb via a nongenomic, ERK-dependent pathway",
abstract = "Recently, we demonstrated that aldosterone inhibits HCO3 - absorption in the rat medullary thick ascending limb (MTAL) via a nongenomic pathway blocked by inhibitors of extracellular signal-regulated kinase (ERK) activation. Here we examined the effects on the MTAL of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], which regulates cell functions through nongenomic mechanisms in nonrenal systems. Addition of 1 nM 1,25(OH)2D3 to the bath decreased HCO3 - absorption by 24{\%}, from 15.0 ± 0.3 to 11.4 ± 0.5 pmol·min-1·mm-1 (P < 0.001). This inhibition was maximal within 60 min and was eliminated by pretreatment with actinomycin D, cycloheximide, or inhibitors of protein kinase C. In MTAL bathed with 1 nM aldosterone [added 15-20 min before 1,25(OH)2D 3], the absolute (5.6 ± 0.3 vs. 3.6 ± 0.3 pmol·min-1·mm-1) and fractional (49 ± 2 vs. 24 ± 2{\%}) decreases in HCO3 - absorption induced by 1,25(OH)2D3 were significantly greater than those in the absence of aldosterone (P < 0.05). The effect of aldosterone to potentiate inhibition by 1,25(OH)2D3 was not affected by spironolactone but was eliminated by the MAPK kinase/ERK inhibitor U-0126. U-0126 did not affect inhibition of HCO3 - absorption by 1,25(OH)2D3 alone. Aldosterone induced rapid activation of ERK via a transcription-independent pathway. We conclude that 1) 1,25(OH)2D3 inhibits HCO3 - absorption in the MTAL via a genomic pathway involving protein kinase C, which may contribute to 1,25(OH)2D3-induced regulation of urinary net acid and/or Ca2+ excretion and 2) aldosterone potentiates inhibition by 1,25(OH)2D3 through an ERK-dependent, nongenomic pathway. These results identify a novel regulatory interaction whereby aldosterone acts via nongenomic mechanisms to enhance the genomic response to 1,25(OH)2D3. Aldosterone may influence a broad range of biological processes, including epithelial transport, by modifying the response of target tissues to 1,25(OH)2D 3 stimulation.",
keywords = "1,25-dihydroxycholecalciferol, Acid-base transport, Bicarbonate absorption, Calcium homeostasis, Kidney",
author = "David Good and Thampi George and Bruns Watts",
year = "2003",
month = "11",
language = "English (US)",
volume = "285",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "5 54-5",

}

TY - JOUR

T1 - Aldosterone potentiates 1,25-dihydroxyvitamin D3 action in renal thick ascending limb via a nongenomic, ERK-dependent pathway

AU - Good, David

AU - George, Thampi

AU - Watts, Bruns

PY - 2003/11

Y1 - 2003/11

N2 - Recently, we demonstrated that aldosterone inhibits HCO3 - absorption in the rat medullary thick ascending limb (MTAL) via a nongenomic pathway blocked by inhibitors of extracellular signal-regulated kinase (ERK) activation. Here we examined the effects on the MTAL of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], which regulates cell functions through nongenomic mechanisms in nonrenal systems. Addition of 1 nM 1,25(OH)2D3 to the bath decreased HCO3 - absorption by 24%, from 15.0 ± 0.3 to 11.4 ± 0.5 pmol·min-1·mm-1 (P < 0.001). This inhibition was maximal within 60 min and was eliminated by pretreatment with actinomycin D, cycloheximide, or inhibitors of protein kinase C. In MTAL bathed with 1 nM aldosterone [added 15-20 min before 1,25(OH)2D 3], the absolute (5.6 ± 0.3 vs. 3.6 ± 0.3 pmol·min-1·mm-1) and fractional (49 ± 2 vs. 24 ± 2%) decreases in HCO3 - absorption induced by 1,25(OH)2D3 were significantly greater than those in the absence of aldosterone (P < 0.05). The effect of aldosterone to potentiate inhibition by 1,25(OH)2D3 was not affected by spironolactone but was eliminated by the MAPK kinase/ERK inhibitor U-0126. U-0126 did not affect inhibition of HCO3 - absorption by 1,25(OH)2D3 alone. Aldosterone induced rapid activation of ERK via a transcription-independent pathway. We conclude that 1) 1,25(OH)2D3 inhibits HCO3 - absorption in the MTAL via a genomic pathway involving protein kinase C, which may contribute to 1,25(OH)2D3-induced regulation of urinary net acid and/or Ca2+ excretion and 2) aldosterone potentiates inhibition by 1,25(OH)2D3 through an ERK-dependent, nongenomic pathway. These results identify a novel regulatory interaction whereby aldosterone acts via nongenomic mechanisms to enhance the genomic response to 1,25(OH)2D3. Aldosterone may influence a broad range of biological processes, including epithelial transport, by modifying the response of target tissues to 1,25(OH)2D 3 stimulation.

AB - Recently, we demonstrated that aldosterone inhibits HCO3 - absorption in the rat medullary thick ascending limb (MTAL) via a nongenomic pathway blocked by inhibitors of extracellular signal-regulated kinase (ERK) activation. Here we examined the effects on the MTAL of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], which regulates cell functions through nongenomic mechanisms in nonrenal systems. Addition of 1 nM 1,25(OH)2D3 to the bath decreased HCO3 - absorption by 24%, from 15.0 ± 0.3 to 11.4 ± 0.5 pmol·min-1·mm-1 (P < 0.001). This inhibition was maximal within 60 min and was eliminated by pretreatment with actinomycin D, cycloheximide, or inhibitors of protein kinase C. In MTAL bathed with 1 nM aldosterone [added 15-20 min before 1,25(OH)2D 3], the absolute (5.6 ± 0.3 vs. 3.6 ± 0.3 pmol·min-1·mm-1) and fractional (49 ± 2 vs. 24 ± 2%) decreases in HCO3 - absorption induced by 1,25(OH)2D3 were significantly greater than those in the absence of aldosterone (P < 0.05). The effect of aldosterone to potentiate inhibition by 1,25(OH)2D3 was not affected by spironolactone but was eliminated by the MAPK kinase/ERK inhibitor U-0126. U-0126 did not affect inhibition of HCO3 - absorption by 1,25(OH)2D3 alone. Aldosterone induced rapid activation of ERK via a transcription-independent pathway. We conclude that 1) 1,25(OH)2D3 inhibits HCO3 - absorption in the MTAL via a genomic pathway involving protein kinase C, which may contribute to 1,25(OH)2D3-induced regulation of urinary net acid and/or Ca2+ excretion and 2) aldosterone potentiates inhibition by 1,25(OH)2D3 through an ERK-dependent, nongenomic pathway. These results identify a novel regulatory interaction whereby aldosterone acts via nongenomic mechanisms to enhance the genomic response to 1,25(OH)2D3. Aldosterone may influence a broad range of biological processes, including epithelial transport, by modifying the response of target tissues to 1,25(OH)2D 3 stimulation.

KW - 1,25-dihydroxycholecalciferol

KW - Acid-base transport

KW - Bicarbonate absorption

KW - Calcium homeostasis

KW - Kidney

UR - http://www.scopus.com/inward/record.url?scp=0142020893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142020893&partnerID=8YFLogxK

M3 - Article

VL - 285

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 5 54-5

ER -